๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Does Mycophenolate Mofetil Decrease the Recurrent Acute Rejection in Renal Transplant Recipients

โœ Scribed by Aneesh Srivastava; Vishwajeet Singh; Devendra Kumar; Anant Kumar; R K Sharma

Publisher
Springer Netherlands
Year
2005
Tongue
English
Weight
167 KB
Volume
37
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-term outcome of mycophenolate mofet
Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients
โœ Marion Margaret Aw; Anita Verma; Mohamed Rela; Nigel Heaton; Giorgina Mieli-Verg ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB ๐Ÿ‘ 1 views

Mycophenolate mofetil (MMF) has been used to rescue liver allografts with steroid-resistant rejection (SRR). However, the long-term outcome of these patients is not known. This study evaluates the long-term outcome of MMF rescue therapy for SRR in pediatric liver allograft recipients. Twenty-six chi

Long-term renal function in liver transp
Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): The TRY study
โœ Svetlana Karie-Guigues; Nicolas Janus; Faouzi Saliba; Jerome Dumortier; Christop ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 152 KB ๐Ÿ‘ 1 views

The prevalence of renal insufficiency before and at 1, 12, and 60 months after liver transplantation (LTx; primary endpoint) and the changes in the glomerular filtration rate (GFR) at same time points according to the immunosuppressive regimen (coprimary endpoint) were investigated. The primary outc